Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2014 1
2015 1
2016 3
2017 1
2018 1
2019 2
2020 1
2021 2
2022 4
2023 1
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

16 results

Results by year

Filters applied: . Clear all
Page 1
Locoregional treatment of de novo stage IV breast cancer in the era of modern oncology.
Merloni F, Palleschi M, Gianni C, Casadei C, Curcio A, Romeo A, Rocchi M, Cima S, Sirico M, Sarti S, Cecconetto L, Mariotti M, Di Menna G, De Giorgi U. Merloni F, et al. Among authors: mariotti m. Front Oncol. 2023 Jan 30;13:1083297. doi: 10.3389/fonc.2023.1083297. eCollection 2023. Front Oncol. 2023. PMID: 36793604 Free PMC article. Review.
CDK4/6-Inhibitors Versus Chemotherapy in Advanced HR+/HER2-Negative Breast Cancer: Results and Correlative Biomarker Analyses of the KENDO Randomized Phase II Trial.
Schettini F, Palleschi M, Mannozzi F, Brasó-Maristany F, Cecconetto L, Galván P, Mariotti M, Ferrari A, Scarpi E, Miserocchi A, Nanni O, Sanfeliu E, Prat A, Rocca A, De Giorgi U. Schettini F, et al. Among authors: mariotti m. Oncologist. 2024 Jan 4:oyad337. doi: 10.1093/oncolo/oyad337. Online ahead of print. Oncologist. 2024. PMID: 38175669 Free article.
Prognosis of ALK-rearranged non-small-cell lung cancer patients carrying TP53 mutations.
Canale M, Petracci E, Cravero P, Mariotti M, Minuti G, Metro G, Ludovini V, Baglivo S, Puccetti M, Dubini A, Martinelli G, Delmonte A, Crinò L, Ulivi P. Canale M, et al. Among authors: mariotti m. Transl Oncol. 2022 Sep;23:101471. doi: 10.1016/j.tranon.2022.101471. Epub 2022 Jun 29. Transl Oncol. 2022. PMID: 35779323 Free PMC article.
Prognostic Role of Circulating miRNAs in Early-Stage Non-Small Cell Lung Cancer.
Ulivi P, Petracci E, Marisi G, Baglivo S, Chiari R, Billi M, Canale M, Pasini L, Racanicchi S, Vagheggini A, Delmonte A, Mariotti M, Ludovini V, Bonafè M, Crinò L, Grignani F. Ulivi P, et al. Among authors: mariotti m. J Clin Med. 2019 Jan 23;8(2):131. doi: 10.3390/jcm8020131. J Clin Med. 2019. PMID: 30678026 Free PMC article.
Computed tomography based analyses of body mass composition in HER2 positive metastatic breast cancer patients undergoing first line treatment with pertuzumab and trastuzumab.
Palleschi M, Prochowski Iamurri A, Scarpi E, Mariotti M, Maltoni R, Mannozzi F, Barone D, Paganelli G, Casi M, Giampalma E, De Giorgi U, Rocca A. Palleschi M, et al. Among authors: mariotti m. Sci Rep. 2022 Mar 1;12(1):3385. doi: 10.1038/s41598-022-07143-1. Sci Rep. 2022. PMID: 35233007 Free PMC article.
Syndrome of inappropriate anti-diuretic hormone secretion in cancer patients: results of the first multicenter Italian study.
Berardi R, Mastroianni C, Lo Russo G, Buosi R, Santini D, Montanino A, Carnaghi C, Tiseo M, Chiari R, Camerini A, Barni S, De Marino V, Ferrari D, Cristofano A, Doni L, Freddari F, Fumagalli D, Portalone L, Sarmiento R, Schinzari G, Sperandi F, Tucci M, Inno A, Ciuffreda L, Mariotti M, Mariani C, Caramanti M, Torniai M, Gallucci R, Bennati C, Bordi P, Buffoni L, Galeassi A, Ghidini M, Grossi E, Morabito A, Vincenzi B, Arvat E. Berardi R, et al. Among authors: mariotti m. Ther Adv Med Oncol. 2019 Sep 27;11:1758835919877725. doi: 10.1177/1758835919877725. eCollection 2019. Ther Adv Med Oncol. 2019. PMID: 31632468 Free PMC article.
16 results